Pablo Lapuerta
Oprichter bij 4m Therapeutics, Inc.
Profiel
Pablo Lapuerta is the founder of 4M Therapeutics, Inc. He previously worked as an Executive Director-Global Medical Affairs at Bristol Myers Squibb Co. from 2009 to 2010.
From 2011 to 2020, he served as the Chief Medical Officer & Executive Vice President at Lexicon Pharmaceuticals, Inc. Prior to that, he was the Chief Medical Officer & SVP-Clinical Strategy at Cogentus Pharmaceuticals, Inc. from 2007 to 2009.
Additionally, he held positions as a Principal at the University of Southern California and Robert Wood Johnson Medical School.
Dr. Lapuerta obtained his doctorate degree from Harvard Medical School and his undergraduate degree from Harvard College.
Actieve functies van Pablo Lapuerta
| Bedrijven | Functie | Begin |
|---|---|---|
| 4m Therapeutics, Inc. | Oprichter | - |
Eerdere bekende functies van Pablo Lapuerta
| Bedrijven | Functie | Einde |
|---|---|---|
| LEXICON PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | 30-09-2020 |
| BRISTOL-MYERS SQUIBB COMPANY | Hoofd Techniek/Wetenschap/O&O | - |
Cogentus Pharmaceuticals, Inc.
 Cogentus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cogentus Pharmaceuticals, Inc. develops pharmaceutical products. Its investors include The Keffi Group, Prospect Venture Partners, Ridgeback Capital, Apothecary Capital, and Pinnacle Ventures. The company was founded by Mark A. Goldsmith in 2006 and is headquartered in Menlo Park, CA | Hoofd Techniek/Wetenschap/O&O | - |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | Corporate Officer/Principal | - |
| Robert Wood Johnson Medical School | Corporate Officer/Principal | - |
Opleiding van Pablo Lapuerta
| Harvard Medical School | Doctorate Degree |
| Harvard College | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| LEXICON PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Cogentus Pharmaceuticals, Inc.
Cogentus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cogentus Pharmaceuticals, Inc. develops pharmaceutical products. Its investors include The Keffi Group, Prospect Venture Partners, Ridgeback Capital, Apothecary Capital, and Pinnacle Ventures. The company was founded by Mark A. Goldsmith in 2006 and is headquartered in Menlo Park, CA | Health Technology |
| 4m Therapeutics, Inc. |
